Insmed Receivables Turnover from 2010 to 2024

INSM Stock  USD 27.25  1.31  4.59%   
Insmed Receivables Turnover yearly trend continues to be very stable with very little volatility. Receivables Turnover is likely to drop to 7.04. During the period from 2010 to 2024, Insmed Receivables Turnover quarterly data regression pattern had sample variance of  10.61 and median of  1.78. View All Fundamentals
 
Receivables Turnover  
First Reported
2010-12-31
Previous Quarter
7.40993955
Current Value
7.04
Quarterly Volatility
3.25677835
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Insmed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insmed main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.1 M, Interest Expense of 80.1 M or Total Revenue of 320.5 M, as well as many exotic indicators such as Price To Sales Ratio of 13.55, Dividend Yield of 0.0 or Days Sales Outstanding of 46.8. Insmed financial statements analysis is a perfect complement when working with Insmed Valuation or Volatility modules.
  
This module can also supplement Insmed's financial leverage analysis and stock options assessment as well as various Insmed Technical models . Check out the analysis of Insmed Correlation against competitors.

Latest Insmed's Receivables Turnover Growth Pattern

Below is the plot of the Receivables Turnover of Insmed Inc over the last few years. It is Insmed's Receivables Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Insmed's overall financial position and show how it may be relating to other accounts over time.
Receivables Turnover10 Years Trend
Slightly volatile
   Receivables Turnover   
       Timeline  

Insmed Receivables Turnover Regression Statistics

Arithmetic Mean4.39
Geometric Mean2.85
Coefficient Of Variation74.16
Mean Deviation3.01
Median1.78
Standard Deviation3.26
Sample Variance10.61
Range9.8431
R-Value0.73
Mean Square Error5.29
R-Squared0.54
Significance0
Slope0.53
Total Sum of Squares148.49

Insmed Receivables Turnover History

2024 7.04
2023 7.41
2022 8.26
2021 7.74
2020 9.93
2019 7.1

About Insmed Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Insmed income statement, its balance sheet, and the statement of cash flows. Insmed investors use historical funamental indicators, such as Insmed's Receivables Turnover, to determine how well the company is positioned to perform in the future. Although Insmed investors may use each financial statement separately, they are all related. The changes in Insmed's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Insmed's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Insmed Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Insmed. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Receivables Turnover 7.41  7.04 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:
Check out the analysis of Insmed Correlation against competitors.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for Insmed Stock analysis

When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Is Insmed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.34)
Revenue Per Share
2.173
Quarterly Revenue Growth
0.411
Return On Assets
(0.28)
Return On Equity
(14.53)
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.